Cholecystectomy Devices Market Size & Growth Forecast 2026–2035, By Segments (Device, Surgery Type, End-use, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Cholecystectomy Devices Market size was estimated at USD 52.12 Million in 2025 and is projected to grow at a 6.9% CAGR from 2026 to 2035, surpassing USD 101.57 Million by 2035. The industry revenue for 2026 is assessed at USD 55.27 million.

• Base Year Value (2025): USD 52.12 Million
• CAGR (2026-2035): 6.9%
• Forecast Year Value (2035): USD 101.57 Million
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Cholecystectomy Devices Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held a 38.74% market share in 2025, supported by high procedural volumes, widespread minimally invasive surgery adoption, advanced hospital infrastructure, and established reimbursement systems.
  • Asia Pacific is projected to grow at a 7.8% CAGR, driven by expanding laparoscopic surgery access, investments in operating room infrastructure, and increasing adoption of minimally invasive procedures.

• Segment Momentum:

  • Conventional cholecystectomy devices led with 85.5% share in 2025 due to deep integration into standard procedures, strong surgeon familiarity, and compatibility with established operating room workflows and procurement practices.
  • Robotic-assisted cholecystectomy devices are the fastest-growing segment as hospitals modernize operating rooms and prioritize precision-driven minimally invasive surgery, improving procedural control and encouraging adoption of advanced surgical platforms.

• Market Expansion Drivers:

  • Rising gallstone prevalence and aging population driving surgical intervention demand.
  • Increasing adoption of laparoscopic and robotic minimally invasive surgical procedures.
  • Expansion of outpatient minimally invasive surgeries improving procedural efficiency.

• Leading Market Participants:

  Top players in the cholecystectomy devices market include Medtronic plc (Ireland), Stryker Corporation (United States), Olympus Corporation (Japan), Intuitive Surgical, Inc. (United States), B. Braun SE (Germany), Sklar Surgical Instruments (United States), Surgical Holdings Limited (United Kingdom), Millennium Surgical Corp. (United States), Surtex Instruments Limited (United Kingdom), GerMedUSA Inc. (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 52.12 Million
  • Projected Market Size: USD 101.57 Million by 2035
  • Growth Forecasts: 6.9% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Conventional Cholecystectomy Devices (Device) | Laparoscopic Cholecystectomy (Surgery Type) | Hospitals (End-use) | Cholecystitis (Indication)
  • Emerging Opportunity Segment: Robotic-assisted Cholecystectomy Surgery Devices (Device) | Laparoscopic Cholecystectomy (Surgery Type) | Ambulatory Surgical Centers (End-use) | Choledocholithiasis (Indication)

Market Growth Drivers and Industry Trends

Rising gallstone prevalence and aging population driving surgical intervention demand

A growing burden of gallstone disease is translating into a larger procedural pipeline for the cholecystectomy devices market, particularly as older patients are more likely to develop symptomatic gallbladder conditions that require surgical management rather than prolonged medical observation. In practice, this raises hospital and surgical center procedure volumes for gallbladder removal, which directly reinforces market demand for trocars, graspers, dissectors, clip appliers, energy devices, and visualization instruments used during cholecystectomy. The aging population also influences case complexity, prompting surgeons and providers to prioritize device reliability, precise hemostasis, and efficient tissue handling, which supports market expansion toward advanced surgical platforms and procedure-specific instruments.

Increasing adoption of laparoscopic and robotic minimally invasive surgical procedures

The shift from open surgery toward laparoscopic and robotic approaches is reshaping product mix and purchasing patterns in the cholecystectomy devices market because minimally invasive cholecystectomy depends on specialized access, dissection, sealing, clipping, and visualization tools that differ from conventional surgical setups. As surgeons and hospitals standardize these techniques to reduce recovery time, postoperative pain, and length of stay, procurement increasingly favors high-performance laparoscopic instruments, articulating devices, camera systems, and robotic-compatible accessories. This transition is not only driving demand for the market through higher utilization of disposable and precision-engineered devices, but also influencing market adoption of premium technologies that fit minimally invasive workflows.

Expansion of outpatient minimally invasive surgeries improving procedural efficiency

The expansion of ambulatory and same-day gallbladder removal is supporting market development in the cholecystectomy devices market by increasing the value placed on speed, workflow consistency, and low-complication procedural execution. Outpatient settings tend to favor device portfolios that simplify setup, shorten operative time, and support predictable recovery, which encourages adoption of disposable laparoscopic tools, integrated energy systems, and streamlined access devices. As providers seek to improve case turnover and reduce inpatient resource use, purchasing decisions increasingly align with products that make minimally invasive cholecystectomy more standardized and operationally efficient, contributing to market size growth through higher procedural throughput and broader site-of-care penetration.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising gallstone prevalence and aging population driving surgical intervention demand	2.50%	High	North America, Europe, Asia Pacific	High	Near Term
Increasing adoption of laparoscopic and robotic minimally invasive surgical procedures	2.00%	High	North America, Europe	High	Mid Term
Expansion of outpatient minimally invasive surgeries improving procedural efficiency	1.60%	High	North America, Asia Pacific	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 38.74% share of the cholecystectomy devices market in 2025, bolstered by the region’s high procedural volume, broad access to minimally invasive surgery, and established hospital procurement for advanced laparoscopic equipment. Market activity is aided by the routine clinical adoption of cholecystectomy procedures, where surgeons rely on dependable visualization, energy, and closure devices in well-equipped operating settings. Strong reimbursement structures and the presence of experienced surgical teams also help sustain replacement demand and steady utilization across ambulatory and inpatient care environments.

Asia Pacific is projected to expand at a 7.8% CAGR over the forecast period, with growth in the cholecystectomy devices market being fueled by the rising availability of laparoscopic surgery across large patient populations and improving surgical capacity in developing healthcare systems. Adoption is accelerating as hospitals increase investment in modern operating room infrastructure and as access to gallbladder surgery becomes more consistent beyond major urban centers. The region’s growth pattern is closely tied to practical expansion in procedural access, equipment installation, and surgeon uptake of minimally invasive techniques.

Key Country Insights

United States

Advanced Minimally Invasive Care

The U.S. cholecystectomy devices market continues advancing through widespread adoption of laparoscopic and robotic-assisted surgical techniques. Healthcare providers in the U.S. prioritize precision instruments that improve procedural efficiency, patient recovery, and operating room workflow.

Japan

Procedure Efficiency Focus

Japan prioritizes cholecystectomy devices that improve surgical precision while supporting efficient hospital workflows. Medical institutions in Japan increasingly adopt compact, technologically advanced laparoscopic equipment to optimize patient outcomes and reduce procedural complexity.

South Korea

Surgical Technology Adoption

South Korea continues strengthening its cholecystectomy devices market through rapid adoption of advanced laparoscopic platforms and digital surgical technologies. Healthcare providers in South Korea increasingly integrate modern visualization and energy devices into routine gallbladder surgery procedures.

Germany

Precision Surgical Systems

Germany emphasizes high-quality cholecystectomy devices designed to support standardized minimally invasive surgical procedures. Hospitals across Germany continue investing in reliable visualization systems and advanced surgical instruments that enhance procedural accuracy and clinical efficiency.

France

Hospital Modernization Support

France is expanding the use of advanced cholecystectomy devices as hospitals modernize minimally invasive surgical capabilities. French healthcare providers continue prioritizing reliable surgical platforms that improve procedural consistency while supporting efficient patient management.

Italy

Laparoscopic Procedure Expansion

Italy maintains steady demand for cholecystectomy devices that support minimally invasive surgical practices across public and private healthcare facilities. Medical centers in Italy continue upgrading laparoscopic equipment to improve procedural performance and enhance surgical outcomes.

Segment Leadership and Growth Trends

  Device Segment Analysis: Conventional Cholecystectomy Devices (Largest Segment) vs Robotic-assisted Cholecystectomy Surgery Devices (Fastest-Growing Segment)

Conventional Cholecystectomy Devices held the leading position in the cholecystectomy devices market in 2025, accounting for an 85.5% share. This dominance is sustained by their deep integration into standard gallbladder removal procedures, broad hospital familiarity, and routine use across established surgical workflows. In the cholecystectomy devices market, conventional instruments remain the practical choice for high-volume clinical settings because they align with existing surgeon training, operating room protocols, and procurement patterns without requiring major workflow changes.

Robotic-assisted Cholecystectomy Surgery Devices are emerging as the fastest-growing segment in the cholecystectomy devices market as providers increasingly adopt more technology-enabled surgical platforms for minimally invasive procedures. Their momentum is tied to the growing preference for greater procedural control and precision within complex surgical environments, which makes them more attractive relative to conventional alternatives in facilities that are expanding advanced surgery capabilities. As healthcare systems continue to modernize operating rooms, robotic-assisted cholecystectomy surgery devices are seeing wider adoption where investment in upgraded surgical infrastructure supports broader adoption.

Surgery Type Segment Analysis: Laparoscopic Cholecystectomy (Largest & Fastest-Growing Segment)

Laparoscopic Cholecystectomy led the cholecystectomy devices market in 2025 with a 76.42% share, while also remaining the fastest-growing surgery type segment. Its continued strength comes from its established role as the preferred minimally invasive approach for gallbladder removal, reinforced through routine clinical adoption and consistent use of specialized surgical instruments. In the cholecystectomy devices market, this segment maintains growth momentum because healthcare providers continue to favor procedures that fit efficient operating room workflows and standard minimally invasive practice patterns, reinforcing both current volume leadership and ongoing demand for laparoscopic-compatible devices.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Device	Conventional Cholecystectomy Devices, Robotic-assisted Cholecystectomy Surgery Devices	Conventional Cholecystectomy Devices	Robotic-assisted Cholecystectomy Surgery Devices
Surgery Type	Laparoscopic Cholecystectomy, Open Cholecystectomy	Laparoscopic Cholecystectomy	Laparoscopic Cholecystectomy
End-use	Hospitals, Ambulatory Surgical Centers, Others	Hospitals	Ambulatory Surgical Centers
Indication	Cholelithiasis, Choledocholithiasis, Cholecystitis, Pancreatitis, Others	Cholecystitis	Choledocholithiasis

Competitive Landscape and Market Positioning

Major players in the cholecystectomy devices market:

1. Medtronic plc (Ireland)

2. Stryker Corporation (United States)

3. Olympus Corporation (Japan)

4. Intuitive Surgical Inc. (United States)

5. B. Braun SE (Germany)

6. Sklar Surgical Instruments (United States)

7. Surgical Holdings Limited (United Kingdom)

8. Millennium Surgical Corp. (United States)

9. Surtex Instruments Limited (United Kingdom)

10. GerMedUSA Inc. (United States)

Advances in minimally invasive surgery are strengthening the cholecystectomy devices market, with research focused on enhanced visualization systems, precision surgical instruments, and improved laparoscopic technologies that support safer procedures and faster patient recovery.